Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 2/2008

01.02.2008

Impact of Changing Epidemiology of Gastroesophageal Reflux Disease on its Diagnosis and Treatment

verfasst von: Hugo Bonatti, Sami R. Achem, Ronald A. Hinder

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Gastroesophageal reflux disease (GERD) has emerged as one of the most common diseases in modern civilization. This article reviews selected changes in epidemiology of GERD during the past decade and provides information on treatment options with a focus on the impact of GERD and potential role of laparoscopic antireflux surgery in patients with diabetes mellitus, obesity, liver cirrhosis, at the extremes of life age and in immunocompromised individuals such as liver and lung transplant recipients.
Literatur
1.
Zurück zum Zitat Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710–717.PubMed Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710–717.PubMed
2.
Zurück zum Zitat Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448–1456.PubMed Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448–1456.PubMed
3.
Zurück zum Zitat Heading RC. Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol Suppl 1999;231:3–8.PubMed Heading RC. Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol Suppl 1999;231:3–8.PubMed
4.
Zurück zum Zitat Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999;106:642–649.PubMed Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999;106:642–649.PubMed
5.
Zurück zum Zitat Haruma K. Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther 2004;20 Suppl 8:40–44.PubMed Haruma K. Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther 2004;20 Suppl 8:40–44.PubMed
6.
Zurück zum Zitat Fukuchi T, Ashida K, Yamashita H, Kiyota N, Tsukamoto R, Takahashi H, Ito D, Nagamatsu R. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer. J Gastroenterol 2005;40:350–360.PubMed Fukuchi T, Ashida K, Yamashita H, Kiyota N, Tsukamoto R, Takahashi H, Ito D, Nagamatsu R. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer. J Gastroenterol 2005;40:350–360.PubMed
7.
Zurück zum Zitat Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003;290:66–72.PubMed Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003;290:66–72.PubMed
8.
Zurück zum Zitat Nishida T, Tsuji S, Tsujii M, Arimitsu S, Sato T, Haruna Y, Miyamoto T, Kanda T, Kawano S, Hori M. Gastroesophageal reflux disease related to diabetes: analysis of 241 cases with type 2 diabetes mellitus. J Gastoenterol Hepatol 2004;19:258–265. Nishida T, Tsuji S, Tsujii M, Arimitsu S, Sato T, Haruna Y, Miyamoto T, Kanda T, Kawano S, Hori M. Gastroesophageal reflux disease related to diabetes: analysis of 241 cases with type 2 diabetes mellitus. J Gastoenterol Hepatol 2004;19:258–265.
9.
Zurück zum Zitat Malfertheiner P, Hallerback B. Clinical manifestations and complications of gastroesophageal reflux disease (GERD). Int J Clin Pract 2005;97:575–583. Malfertheiner P, Hallerback B. Clinical manifestations and complications of gastroesophageal reflux disease (GERD). Int J Clin Pract 2005;97:575–583.
10.
Zurück zum Zitat Castell DO, Kahrilas PJ, Richter JE, Vakil NB, Johnson DA, Zuckerman S, Skammer W, Levine JG. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 2002;97:575–583.PubMed Castell DO, Kahrilas PJ, Richter JE, Vakil NB, Johnson DA, Zuckerman S, Skammer W, Levine JG. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 2002;97:575–583.PubMed
11.
Zurück zum Zitat Bammer T, Hinder RA, Klaus A, Klinger PJ. Five- to eight-year outcome of the first laparoscopic Nissen fundoplications. J Gastrointest Surg 2001;5:42–48.PubMed Bammer T, Hinder RA, Klaus A, Klinger PJ. Five- to eight-year outcome of the first laparoscopic Nissen fundoplications. J Gastrointest Surg 2001;5:42–48.PubMed
12.
Zurück zum Zitat Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Areus L. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005;40:275–285.PubMed Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Areus L. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005;40:275–285.PubMed
13.
Zurück zum Zitat Wu CH, Wu MS, Huang SP, Lin JT. Relationship between Helicobacter pylori infection and erosive gastroesophageal reflux disease. J Formos Med Assoc 2004;103:186–190.PubMed Wu CH, Wu MS, Huang SP, Lin JT. Relationship between Helicobacter pylori infection and erosive gastroesophageal reflux disease. J Formos Med Assoc 2004;103:186–190.PubMed
14.
Zurück zum Zitat Fass R, Quan SF, O’Connor GT, Ervin A, Iber C. Predictors of heartburn during sleep in a large prospective cohort study. Chest 2005;127:1658–1666.PubMed Fass R, Quan SF, O’Connor GT, Ervin A, Iber C. Predictors of heartburn during sleep in a large prospective cohort study. Chest 2005;127:1658–1666.PubMed
15.
Zurück zum Zitat Arents NL, Thijs JC, van Zwet AA, Kleibeuker JH. Does the declining prevalence of Helicobacter pylori unmask patients with idiophatic peptic ulcer disease? Trends over an 8 year period. Eur J Gastroenterol Hepatol 2004;16:779–783.PubMed Arents NL, Thijs JC, van Zwet AA, Kleibeuker JH. Does the declining prevalence of Helicobacter pylori unmask patients with idiophatic peptic ulcer disease? Trends over an 8 year period. Eur J Gastroenterol Hepatol 2004;16:779–783.PubMed
16.
Zurück zum Zitat Sullivan T, Ashbury FD, Fallone CA, Naja F, Schabas R, Hebert PC, Hunt R, Jones N. Helicobacter pylori and the prevention of gastric cancer. Can J Gastroenterol 2004;18:295–302.PubMed Sullivan T, Ashbury FD, Fallone CA, Naja F, Schabas R, Hebert PC, Hunt R, Jones N. Helicobacter pylori and the prevention of gastric cancer. Can J Gastroenterol 2004;18:295–302.PubMed
17.
Zurück zum Zitat Delaney B, McColl K. Review article: Helicobacter pylori and gastro-esophageal reflux disease. Aliment Pharmacol Ther 2005;22 Suppl 1:32–40.PubMed Delaney B, McColl K. Review article: Helicobacter pylori and gastro-esophageal reflux disease. Aliment Pharmacol Ther 2005;22 Suppl 1:32–40.PubMed
18.
Zurück zum Zitat DiBaise JK. A randomized, double-blind comparison of the two different coffee-roasting processes on development of heartburn and dyspepsia in coffee-sensitive individuals. Dig Dis Sci 2003;48:652–656.PubMed DiBaise JK. A randomized, double-blind comparison of the two different coffee-roasting processes on development of heartburn and dyspepsia in coffee-sensitive individuals. Dig Dis Sci 2003;48:652–656.PubMed
19.
Zurück zum Zitat Pehl C, Frommherz M, Wendl B, Pfeiffer A. Gastroesophageal reflux induced by white wine: the role of acid clearance and “rereflux”. Am J Gastroenterol 2002;97:561–567.PubMed Pehl C, Frommherz M, Wendl B, Pfeiffer A. Gastroesophageal reflux induced by white wine: the role of acid clearance and “rereflux”. Am J Gastroenterol 2002;97:561–567.PubMed
20.
Zurück zum Zitat Tyber MA. The relationship between hiatus hernia and tricyclic and antidepressants: a report of five cases. Am J Psychiatry 1975;132:652–653.PubMed Tyber MA. The relationship between hiatus hernia and tricyclic and antidepressants: a report of five cases. Am J Psychiatry 1975;132:652–653.PubMed
21.
Zurück zum Zitat Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Lifestyle related factors in the aetiology of gastro-oesophageal reflux. Gut 2004;53:1730–1735.PubMed Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Lifestyle related factors in the aetiology of gastro-oesophageal reflux. Gut 2004;53:1730–1735.PubMed
22.
Zurück zum Zitat Cappell MS. Clinical presentation, diagnosis, and management of gastroesophageal reflux disease. Med Clin North Am 2005;89:243–291.PubMed Cappell MS. Clinical presentation, diagnosis, and management of gastroesophageal reflux disease. Med Clin North Am 2005;89:243–291.PubMed
23.
Zurück zum Zitat Kahrilas PJ, Lee TJ. Pathophysiology of gastroesophageal reflux disease. Thorac Surg Clin 2005;15:323–333.PubMed Kahrilas PJ, Lee TJ. Pathophysiology of gastroesophageal reflux disease. Thorac Surg Clin 2005;15:323–333.PubMed
24.
Zurück zum Zitat Scheffer RC, Gooszen HG, Hebbard GS, Samson M. The role of transsphincteric pressure and proximal gastric volume in acid reflux before and after fundoplication. Gastroenterology 2005;129:1900–1909.PubMed Scheffer RC, Gooszen HG, Hebbard GS, Samson M. The role of transsphincteric pressure and proximal gastric volume in acid reflux before and after fundoplication. Gastroenterology 2005;129:1900–1909.PubMed
25.
Zurück zum Zitat Brunton S, McGuigan J. Diagnostic challenges: differentiating nighttime GERD. J Fam Pract 2005;54:1073–1078.PubMed Brunton S, McGuigan J. Diagnostic challenges: differentiating nighttime GERD. J Fam Pract 2005;54:1073–1078.PubMed
26.
Zurück zum Zitat Lenglinger J, Eisler M, Riegler M. Obesity and GERD: implications and consequences for bariatic surgery? Am J Gastroenterol 2005;100:2600–2601.PubMed Lenglinger J, Eisler M, Riegler M. Obesity and GERD: implications and consequences for bariatic surgery? Am J Gastroenterol 2005;100:2600–2601.PubMed
27.
Zurück zum Zitat Ahlawat SK, Mohi-Ud-Din R, Williams DC, Maher KA, Benjamin SB. A prospective study of gastric acid analysis and esophageal acid exposure in patients with gastroesophageal reflux refractory to medical therapy. Dig Dis Sci 2005;50:2019–2024.PubMed Ahlawat SK, Mohi-Ud-Din R, Williams DC, Maher KA, Benjamin SB. A prospective study of gastric acid analysis and esophageal acid exposure in patients with gastroesophageal reflux refractory to medical therapy. Dig Dis Sci 2005;50:2019–2024.PubMed
28.
Zurück zum Zitat Armstrong D. Gastroesophageal reflux disease. Curr Opin Pharmacol 2005;5:589–595.PubMed Armstrong D. Gastroesophageal reflux disease. Curr Opin Pharmacol 2005;5:589–595.PubMed
29.
Zurück zum Zitat Frisby CL, Mattsson JP, Jensen JM, Lehmann A, Dent J, Blackshaw LA. Inhibition of transient lower esophageal sphincter relaxation and gastroesophageal reflux by metabotropic glutamate receptor ligands. Gastroenterology 2005;129:995–1004.PubMed Frisby CL, Mattsson JP, Jensen JM, Lehmann A, Dent J, Blackshaw LA. Inhibition of transient lower esophageal sphincter relaxation and gastroesophageal reflux by metabotropic glutamate receptor ligands. Gastroenterology 2005;129:995–1004.PubMed
30.
Zurück zum Zitat Alvarez-Sanchez A, Rey E, Achem SR, Diaz-Rubio M. Does progesterone fluctuation across the menstrual cycle predispose to gastroesophageal reflux? Am J Gastroenterol 1999;94:1468–1471.PubMed Alvarez-Sanchez A, Rey E, Achem SR, Diaz-Rubio M. Does progesterone fluctuation across the menstrual cycle predispose to gastroesophageal reflux? Am J Gastroenterol 1999;94:1468–1471.PubMed
31.
Zurück zum Zitat Katz PO, Castell DO. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am 1998;27:153–167.PubMed Katz PO, Castell DO. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am 1998;27:153–167.PubMed
32.
Zurück zum Zitat Simpson JA, Conn HO. Role of ascites in gastroesophageal reflux with comments on the pathogenesis of bleeding esophageal varices. Gastroenterology 1968;55:17–25.PubMed Simpson JA, Conn HO. Role of ascites in gastroesophageal reflux with comments on the pathogenesis of bleeding esophageal varices. Gastroenterology 1968;55:17–25.PubMed
33.
Zurück zum Zitat Day JP, Richter JE. Medical and surgical conditions predisposing to gastroesophageal reflux disease. Gastroenterol Clin North Am 1990;19:587–607.PubMed Day JP, Richter JE. Medical and surgical conditions predisposing to gastroesophageal reflux disease. Gastroenterol Clin North Am 1990;19:587–607.PubMed
34.
Zurück zum Zitat Carry PY, Banssillon V. [Intra-abdominal pressure]. Ann Fr Anesth Reanim 1994;13:381–399.PubMed Carry PY, Banssillon V. [Intra-abdominal pressure]. Ann Fr Anesth Reanim 1994;13:381–399.PubMed
35.
Zurück zum Zitat Navarro-Rodriguez T, Hashimoto CL, Carrilho FJ, Strauss E, Laudanna AA, Moraes-Filho JP. Reduction of abdominal pressure in patients with ascites reduces gastroesophageal reflux. Dis Esophagus 2003;16:77–82.PubMed Navarro-Rodriguez T, Hashimoto CL, Carrilho FJ, Strauss E, Laudanna AA, Moraes-Filho JP. Reduction of abdominal pressure in patients with ascites reduces gastroesophageal reflux. Dis Esophagus 2003;16:77–82.PubMed
36.
Zurück zum Zitat Laurencin MG, Goldschmidt R, Fisher L. Type 2 diabetes in adolescents. How to recognize and treat this growing problem. Postgrad Med 2005;118:31–36, 43.PubMed Laurencin MG, Goldschmidt R, Fisher L. Type 2 diabetes in adolescents. How to recognize and treat this growing problem. Postgrad Med 2005;118:31–36, 43.PubMed
37.
Zurück zum Zitat Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199–211.PubMed Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199–211.PubMed
38.
Zurück zum Zitat Spivak H, Hewitt MF, Onn A, Half EE. Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure. Am J Surg 2005;189:27–32.PubMed Spivak H, Hewitt MF, Onn A, Half EE. Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure. Am J Surg 2005;189:27–32.PubMed
39.
Zurück zum Zitat Aro P, Ronkainen J, Talley NJ, Storskrubb T, Bolling-Sternevald E, Agreus L. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut 2005;54:1377–1383.PubMed Aro P, Ronkainen J, Talley NJ, Storskrubb T, Bolling-Sternevald E, Agreus L. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut 2005;54:1377–1383.PubMed
40.
Zurück zum Zitat Dolan K, Finch R, Fielding G. Laparoscopic gastric banding and crural repair in the obese patient with a hiatal hernia. Obes Surg 2003;13:772–775.PubMed Dolan K, Finch R, Fielding G. Laparoscopic gastric banding and crural repair in the obese patient with a hiatal hernia. Obes Surg 2003;13:772–775.PubMed
41.
Zurück zum Zitat Landen S. Simultaneous paraesophageal hernia repair and gastric banding. Obes Surg 2005;15:435–438.PubMed Landen S. Simultaneous paraesophageal hernia repair and gastric banding. Obes Surg 2005;15:435–438.PubMed
42.
Zurück zum Zitat D’Alessio MJ, Arnaoutakis D, Giarelli N, Villadolid DV, Rosemurgy AS. Obesity is not a contraindication to laparoscopic Nissen fundoplication. J Gastrointest Surg 2005;9:949–954.PubMed D’Alessio MJ, Arnaoutakis D, Giarelli N, Villadolid DV, Rosemurgy AS. Obesity is not a contraindication to laparoscopic Nissen fundoplication. J Gastrointest Surg 2005;9:949–954.PubMed
43.
Zurück zum Zitat Patterson EJ, Davis DG, Khajanchee Y, Swanstrom LL. Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn. Surg Endosc 2003;17:1561–1565.PubMed Patterson EJ, Davis DG, Khajanchee Y, Swanstrom LL. Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn. Surg Endosc 2003;17:1561–1565.PubMed
44.
Zurück zum Zitat Gold BD. Asthma and gastroesophageal reflux disease in children: exploring the relationship. J Pediatr 2005;146:S13–S20.PubMed Gold BD. Asthma and gastroesophageal reflux disease in children: exploring the relationship. J Pediatr 2005;146:S13–S20.PubMed
45.
Zurück zum Zitat Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. J Pediatr 2005;146:S3–S12.PubMed Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. J Pediatr 2005;146:S3–S12.PubMed
46.
Zurück zum Zitat Esposito C, Langer JC, Schaarschmidt K, Mattioli G, Sauer C, Centonze A, Cigliano B, Settimi A, Jasonni V. Laparoscopic antireflux procedures in the management of gastroesophageal reflux following esophageal atresia repair. J Pediatr Gastroenterol Nutr 2005;40:349–351.PubMed Esposito C, Langer JC, Schaarschmidt K, Mattioli G, Sauer C, Centonze A, Cigliano B, Settimi A, Jasonni V. Laparoscopic antireflux procedures in the management of gastroesophageal reflux following esophageal atresia repair. J Pediatr Gastroenterol Nutr 2005;40:349–351.PubMed
47.
Zurück zum Zitat Rothenberg SS. The first decade’s experience with laparoscopic Nissen fundoplication in infants and children. J. Pediatr Surg 2005;40:142–146; discussion 147.PubMed Rothenberg SS. The first decade’s experience with laparoscopic Nissen fundoplication in infants and children. J. Pediatr Surg 2005;40:142–146; discussion 147.PubMed
48.
Zurück zum Zitat Scarupa MD, Mori N, Canning BJ. Gastroesophageal reflux disease in children with asthma: treatment implications. Paediatr Drugs 2005;7:177–186.PubMed Scarupa MD, Mori N, Canning BJ. Gastroesophageal reflux disease in children with asthma: treatment implications. Paediatr Drugs 2005;7:177–186.PubMed
49.
Zurück zum Zitat Diaz DM, Gibbons TE, Heiss K, Wulkan ML, Ricketts RR, Gold BD. Antireflux surgery outcomes in pediatric gastroesophageal reflux disease. Am J Gastroenterol 2005;100:1844–1852.PubMed Diaz DM, Gibbons TE, Heiss K, Wulkan ML, Ricketts RR, Gold BD. Antireflux surgery outcomes in pediatric gastroesophageal reflux disease. Am J Gastroenterol 2005;100:1844–1852.PubMed
50.
Zurück zum Zitat Stordal K, Johannesdottir GB, Bentsen BS, Sandvik L. Gastroesophageal reflux disease in children: association between symptoms and pH monitoring. Scand J Gastroenterol 2005;40:636–640.PubMed Stordal K, Johannesdottir GB, Bentsen BS, Sandvik L. Gastroesophageal reflux disease in children: association between symptoms and pH monitoring. Scand J Gastroenterol 2005;40:636–640.PubMed
51.
Zurück zum Zitat Liu DC, Somme S, Mavrelis PG, Hurwich D, Statter MB, Teitelbaum DH, Zimmermann BT, Jackson CC, Dye C. Stretta as the initial antireflux procedure in children. J Pediatr Surg 2005;40:148–151; discussion 151–142.PubMed Liu DC, Somme S, Mavrelis PG, Hurwich D, Statter MB, Teitelbaum DH, Zimmermann BT, Jackson CC, Dye C. Stretta as the initial antireflux procedure in children. J Pediatr Surg 2005;40:148–151; discussion 151–142.PubMed
52.
Zurück zum Zitat Richter JE. Gasroesophageal reflux disease in the older patient: presentations, treatment, and complications. Am J Gastroenterol 2000;95:368–373.PubMed Richter JE. Gasroesophageal reflux disease in the older patient: presentations, treatment, and complications. Am J Gastroenterol 2000;95:368–373.PubMed
53.
Zurück zum Zitat Achem AC, Achem SR, Stark ME, DeVault KR. Failure of esophageal peristalsis in older patients: association with esophageal acid exposure. Am J Gastroenterol 2003;98:35–39.PubMed Achem AC, Achem SR, Stark ME, DeVault KR. Failure of esophageal peristalsis in older patients: association with esophageal acid exposure. Am J Gastroenterol 2003;98:35–39.PubMed
54.
Zurück zum Zitat Triadafilopoulos G, Sharma R. Features of symptomatic gastroesophageal reflux disease in elderly patients. Am J Gastroenterol 1997;92:2007–2011.PubMed Triadafilopoulos G, Sharma R. Features of symptomatic gastroesophageal reflux disease in elderly patients. Am J Gastroenterol 1997;92:2007–2011.PubMed
55.
Zurück zum Zitat Mold JW, Reed LE, Davis AB, Allen ML, Decktor DL, Robinson M. Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol 1991;86:965–970.PubMed Mold JW, Reed LE, Davis AB, Allen ML, Decktor DL, Robinson M. Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol 1991;86:965–970.PubMed
56.
Zurück zum Zitat Bammer T, Hinder RA, Klaus A, Libbey JS, Napoliello DA, Rodriquez JA. Safety and long term outcome of laparoscopic antireflux surgery in patients in their eighties and older. Surg Endosc 2002;16:40–42.PubMed Bammer T, Hinder RA, Klaus A, Libbey JS, Napoliello DA, Rodriquez JA. Safety and long term outcome of laparoscopic antireflux surgery in patients in their eighties and older. Surg Endosc 2002;16:40–42.PubMed
57.
Zurück zum Zitat Fernando HC, Schauer PR, Buenaventura PO, Christie NA, Close JM, Luketich JD. Outcomes of minimally invasive antireflux operations in the elderly: a comparative review. JSLS 2003;2:311–315. Fernando HC, Schauer PR, Buenaventura PO, Christie NA, Close JM, Luketich JD. Outcomes of minimally invasive antireflux operations in the elderly: a comparative review. JSLS 2003;2:311–315.
58.
Zurück zum Zitat Coelho JC, Campos AC, Costa MA, Soares RV, Fauez RA. Complications of laparoscopic fundoplication in the elderly. Surg Laparosc Endosc Percutan Tech 2003;13:6–10.PubMed Coelho JC, Campos AC, Costa MA, Soares RV, Fauez RA. Complications of laparoscopic fundoplication in the elderly. Surg Laparosc Endosc Percutan Tech 2003;13:6–10.PubMed
59.
Zurück zum Zitat Jackson AL, Rashed H, Cardoso S, Wong F, Werkman R, Thompson J, Abell TL. Assessment of gastric electrical activity and autonomic function among diabetic and nondiabetic patients with symptoms of gastroesphageal reflux. Dig Dis Sci 2000;45:1727–1730.PubMed Jackson AL, Rashed H, Cardoso S, Wong F, Werkman R, Thompson J, Abell TL. Assessment of gastric electrical activity and autonomic function among diabetic and nondiabetic patients with symptoms of gastroesphageal reflux. Dig Dis Sci 2000;45:1727–1730.PubMed
60.
Zurück zum Zitat Lluch I, Ascaso JF, Mora F, Minguez M, Pena A, Hernendez A, Benages A. Gastroesphageal reflux in diabetis mellitus. Am J Gastroenterol 1999;94:919–924.PubMed Lluch I, Ascaso JF, Mora F, Minguez M, Pena A, Hernendez A, Benages A. Gastroesphageal reflux in diabetis mellitus. Am J Gastroenterol 1999;94:919–924.PubMed
61.
Zurück zum Zitat Murray FE, Lombard MG, Ashe J, Lynch D, Drury MI, O’Moore B, Lennon J, Crowe J. Esophageal function in diabetes mellitus with special reference to acid studies and relationship to peripheral neuropathy. Am J Gastroenterol 1987;82:840–843.PubMed Murray FE, Lombard MG, Ashe J, Lynch D, Drury MI, O’Moore B, Lennon J, Crowe J. Esophageal function in diabetes mellitus with special reference to acid studies and relationship to peripheral neuropathy. Am J Gastroenterol 1987;82:840–843.PubMed
62.
Zurück zum Zitat Rosztoczy A, Roka R, Varkonyi TT, Lengyel C, Izbeki F, Lonovics J, Wittman T. Regional differences in the manifestation of gastrointestinal motor disorder in type 1 diabetic patients with autonomic neuropathy. Z Gastroenterol 2004;42:1295–1300.PubMed Rosztoczy A, Roka R, Varkonyi TT, Lengyel C, Izbeki F, Lonovics J, Wittman T. Regional differences in the manifestation of gastrointestinal motor disorder in type 1 diabetic patients with autonomic neuropathy. Z Gastroenterol 2004;42:1295–1300.PubMed
63.
Zurück zum Zitat Hinder RA, Stein HJ, Bremmer CG, DeMeester TR. Relationship of a satisfactory outcome to normalization of delayed gastric emptying after Nissen fundoplication. Ann Surg 1989;210:458–464; discussion 464–455.PubMed Hinder RA, Stein HJ, Bremmer CG, DeMeester TR. Relationship of a satisfactory outcome to normalization of delayed gastric emptying after Nissen fundoplication. Ann Surg 1989;210:458–464; discussion 464–455.PubMed
64.
Zurück zum Zitat Schwizer W, Hinder RA, DeMeester TR. Does delayed gastric emptying contribute to gastroesphageal reflux disease? Am J Surg 1989;157:74–81.PubMed Schwizer W, Hinder RA, DeMeester TR. Does delayed gastric emptying contribute to gastroesphageal reflux disease? Am J Surg 1989;157:74–81.PubMed
65.
Zurück zum Zitat Benini L, Sembenini C, Castellani G, Caliari S, Fioretta A, Vantini I. Gastric emptying and dyspeptic symptoms in patients with gastroesphageal reflux. Am J Gastroenterol 1996;91:1351–1354.PubMed Benini L, Sembenini C, Castellani G, Caliari S, Fioretta A, Vantini I. Gastric emptying and dyspeptic symptoms in patients with gastroesphageal reflux. Am J Gastroenterol 1996;91:1351–1354.PubMed
66.
Zurück zum Zitat Emerenziani S, Sifrim D. Gastroesphageal reflux and gastric emptying, revisited. Curr Gastroenterol Rep 2005;7:190–195.PubMed Emerenziani S, Sifrim D. Gastroesphageal reflux and gastric emptying, revisited. Curr Gastroenterol Rep 2005;7:190–195.PubMed
67.
Zurück zum Zitat Forster J, Sarosiek I, Delcore R, Lin Z, Raju GS, McCallum RW. Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg 2001;182:676–681.PubMed Forster J, Sarosiek I, Delcore R, Lin Z, Raju GS, McCallum RW. Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg 2001;182:676–681.PubMed
68.
Zurück zum Zitat Shen B, Soffer EE. Diabetic gastropathy: a practical approach to a vexing problem. Cleve Clin J Med 2000;67:659–664.PubMed Shen B, Soffer EE. Diabetic gastropathy: a practical approach to a vexing problem. Cleve Clin J Med 2000;67:659–664.PubMed
69.
Zurück zum Zitat Kinekawa F, Kubo F, Matsuda K, Fujita Y, Kobayashi M, Funakoshi F, Uchida N, Watanabe S, Tomita T, Uchida Y, Kuriyama S. Effect of an aldose reductase inhibitor on esophageal dysfunction in diabetic patients. Hepatogastroenterology 2005;52:471–474.PubMed Kinekawa F, Kubo F, Matsuda K, Fujita Y, Kobayashi M, Funakoshi F, Uchida N, Watanabe S, Tomita T, Uchida Y, Kuriyama S. Effect of an aldose reductase inhibitor on esophageal dysfunction in diabetic patients. Hepatogastroenterology 2005;52:471–474.PubMed
70.
Zurück zum Zitat Okamoto H, Nomura Y, Uehara K, Saito K, Kimura M, Chikamori K, Ito S. Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis. Intern Med 2003;42:655–664.PubMed Okamoto H, Nomura Y, Uehara K, Saito K, Kimura M, Chikamori K, Ito S. Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis. Intern Med 2003;42:655–664.PubMed
71.
Zurück zum Zitat Pehl C, Pfeiffer A, Wendl B, Stellwag B, Kaess H. Effect of erythromycin on postprandial gastroesophageal reflux in reflux esophagitis. Dis Esophagus 1997;10:34–37.PubMed Pehl C, Pfeiffer A, Wendl B, Stellwag B, Kaess H. Effect of erythromycin on postprandial gastroesophageal reflux in reflux esophagitis. Dis Esophagus 1997;10:34–37.PubMed
72.
Zurück zum Zitat Bashir RM, Wilcox CM. Symptom-specific use of upper gastrointestinal endoscopy in human immunodeficiency virus-infected patients yields high dividends. J Clin Gastrointerol 1996;223:292–298. Bashir RM, Wilcox CM. Symptom-specific use of upper gastrointestinal endoscopy in human immunodeficiency virus-infected patients yields high dividends. J Clin Gastrointerol 1996;223:292–298.
73.
Zurück zum Zitat Troppmann C, Papalois BE, Chiou A, Benedetti E, Dunn DL, Matas AJ, Najarian JS, Gruessner RW. Incidence, complications, treatment, and outcome of ulcers of the upper gastrointestinal tract after renal transplantation during the cyclosporine era. J Am Coll Surg 1995;180:433.PubMed Troppmann C, Papalois BE, Chiou A, Benedetti E, Dunn DL, Matas AJ, Najarian JS, Gruessner RW. Incidence, complications, treatment, and outcome of ulcers of the upper gastrointestinal tract after renal transplantation during the cyclosporine era. J Am Coll Surg 1995;180:433.PubMed
74.
Zurück zum Zitat Spivak H, Smith CD, Philchith A, Galloway K, Waring JP, Hunter JG. Asthma and gastroesophageal reflux: fundoplication decreases need for systemic corticosteroids. J Gastrointest Surg 1999;3:477–482.PubMed Spivak H, Smith CD, Philchith A, Galloway K, Waring JP, Hunter JG. Asthma and gastroesophageal reflux: fundoplication decreases need for systemic corticosteroids. J Gastrointest Surg 1999;3:477–482.PubMed
75.
Zurück zum Zitat Anderson JE, Yim KB, Crowell MD. Prevalence of gastroesophageal reflux disease in peritoneal dialysis and hemodialysis patients. Adv Perit Dial 1999;15:75–78.PubMed Anderson JE, Yim KB, Crowell MD. Prevalence of gastroesophageal reflux disease in peritoneal dialysis and hemodialysis patients. Adv Perit Dial 1999;15:75–78.PubMed
76.
Zurück zum Zitat Arsene D, Bruley des Varannes S, Galmiche JP, Denis P, Chavialle JA, Hellot MF, Ducrotte P, Colin R. Gastro-oesophageal reflux and alcoholic cirrhosis. A reappraisal. J Hepatol 1987;4:250–258.PubMed Arsene D, Bruley des Varannes S, Galmiche JP, Denis P, Chavialle JA, Hellot MF, Ducrotte P, Colin R. Gastro-oesophageal reflux and alcoholic cirrhosis. A reappraisal. J Hepatol 1987;4:250–258.PubMed
77.
Zurück zum Zitat Takatoku M, Muroi K, Kawano-Yamamoto C, Nagai T, Komatsu N, Ozawa K. Involvement of the esophagus and stomach as a first manifestation of varicella zoster virus infection after allogeneic bone marrow transplantation. Intern Med 2004;43:861–864.PubMed Takatoku M, Muroi K, Kawano-Yamamoto C, Nagai T, Komatsu N, Ozawa K. Involvement of the esophagus and stomach as a first manifestation of varicella zoster virus infection after allogeneic bone marrow transplantation. Intern Med 2004;43:861–864.PubMed
78.
Zurück zum Zitat Fantry L. Gastrointestinal infections in the immunocompromised host. Curr Opin Gastroenterol 2003;19:37–41.PubMed Fantry L. Gastrointestinal infections in the immunocompromised host. Curr Opin Gastroenterol 2003;19:37–41.PubMed
79.
Zurück zum Zitat Gaissert HA, Roper CL, Patterson GA, Grillo HC. Infectious necrotizing esophagitis: outcome after medical and surgical intervention. Ann Thorac Surg 2003;75:342–347.PubMed Gaissert HA, Roper CL, Patterson GA, Grillo HC. Infectious necrotizing esophagitis: outcome after medical and surgical intervention. Ann Thorac Surg 2003;75:342–347.PubMed
80.
Zurück zum Zitat Ponticelli C, Passerini P. Gastrointestinal complications in renal transplant recipients. Transpl Int 2005;18:643–650.PubMed Ponticelli C, Passerini P. Gastrointestinal complications in renal transplant recipients. Transpl Int 2005;18:643–650.PubMed
81.
Zurück zum Zitat Guilbeau JM. Delayed wound healing with sirolimus after liver transplant. Ann Pharmacother 2002;36:1391–1395.PubMed Guilbeau JM. Delayed wound healing with sirolimus after liver transplant. Ann Pharmacother 2002;36:1391–1395.PubMed
82.
Zurück zum Zitat Helling TS. Perforation of the stomach during laparoscopic Nissen fundoplication in a patient on chronic corticosteroid therapy. Surg Endosc 1995;9:1146.PubMed Helling TS. Perforation of the stomach during laparoscopic Nissen fundoplication in a patient on chronic corticosteroid therapy. Surg Endosc 1995;9:1146.PubMed
83.
Zurück zum Zitat Lau CL, Palmer SM, Howell DN, McMahon R, Hadjiliadis D, Gaca J, Pappas TN, Davis RD, Eubanks S. Laparoscopic antireflux surgery in the lung transplant population. Surg Endosc 2002;16:1674–1678.PubMed Lau CL, Palmer SM, Howell DN, McMahon R, Hadjiliadis D, Gaca J, Pappas TN, Davis RD, Eubanks S. Laparoscopic antireflux surgery in the lung transplant population. Surg Endosc 2002;16:1674–1678.PubMed
84.
Zurück zum Zitat O’Halloran EK, Reynolds JD, Lau CL, Manson RJ, Davis RD, Palmer SM, Pappas TN, Clary EM, Eubanks WS. Lapasropic Nissen fundoplication for treating reflux in the lung transplant recipients. J Gastrointest Surg 2004;8:132–137.PubMed O’Halloran EK, Reynolds JD, Lau CL, Manson RJ, Davis RD, Palmer SM, Pappas TN, Clary EM, Eubanks WS. Lapasropic Nissen fundoplication for treating reflux in the lung transplant recipients. J Gastrointest Surg 2004;8:132–137.PubMed
85.
Zurück zum Zitat Davis RD Jr, Lau CL, Eubanks S, Messier RH, Hadjiliadis D, Steele MP, Palmer SM. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003;125:533–542.PubMed Davis RD Jr, Lau CL, Eubanks S, Messier RH, Hadjiliadis D, Steele MP, Palmer SM. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003;125:533–542.PubMed
86.
Zurück zum Zitat Benden C, Aurora P, Curry J, Whitmore P, Priestley L, Elliot MJ. High prevalence of gatroesophageal reflux in children after lung transplantation. Pediatr Pulmonol 2005;40:68–71.PubMed Benden C, Aurora P, Curry J, Whitmore P, Priestley L, Elliot MJ. High prevalence of gatroesophageal reflux in children after lung transplantation. Pediatr Pulmonol 2005;40:68–71.PubMed
87.
Zurück zum Zitat Verleden GM, Dupont LJ, Van Raemdonck DE. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur Respir J 2005;25:221–224.PubMed Verleden GM, Dupont LJ, Van Raemdonck DE. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur Respir J 2005;25:221–224.PubMed
88.
Zurück zum Zitat Cantu E 3rd, Appel JZ 3rd, Hartwig MG, Woreta H, Green C, Messier R, Palmer SM, Davis RD Jr. J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004;78:1142–1151; discussion 1142–1151.PubMed Cantu E 3rd, Appel JZ 3rd, Hartwig MG, Woreta H, Green C, Messier R, Palmer SM, Davis RD Jr. J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004;78:1142–1151; discussion 1142–1151.PubMed
89.
Zurück zum Zitat Hartwig MG, Appel JZ, Davis RD. Antireflux surgery in the setting of lung transplantation: strategies for treating gastroesophageal reflux disease in a high-risk population. Thorac Surg Clin 2005;15:417–427.PubMed Hartwig MG, Appel JZ, Davis RD. Antireflux surgery in the setting of lung transplantation: strategies for treating gastroesophageal reflux disease in a high-risk population. Thorac Surg Clin 2005;15:417–427.PubMed
90.
Zurück zum Zitat D’Ovidio F, Mura M, Tsang M, Waddell TK, Hutcheon MA, Singer LG, Hadjiliadis D, Chaparro C, Gutierrez C, Pierre A, Darling G, Liu M, Keshavjee S. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg 2005;129:1144–1152.PubMed D’Ovidio F, Mura M, Tsang M, Waddell TK, Hutcheon MA, Singer LG, Hadjiliadis D, Chaparro C, Gutierrez C, Pierre A, Darling G, Liu M, Keshavjee S. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg 2005;129:1144–1152.PubMed
91.
Zurück zum Zitat Palmer SM, Miralles AP, Howell DN, Brazer SR, Tapson VF, Davis RD. Gastroesophageal reflux as a reversible cause of allograft dysfuntion after lung transplantation. Chest 2000;118:1214–1217.PubMed Palmer SM, Miralles AP, Howell DN, Brazer SR, Tapson VF, Davis RD. Gastroesophageal reflux as a reversible cause of allograft dysfuntion after lung transplantation. Chest 2000;118:1214–1217.PubMed
92.
Zurück zum Zitat Hadjiliadis D, Duane Davis R, Steele MP, Messier RH, Lau CL, Eubanks SS, Palmer SM. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003;17:363–368.PubMed Hadjiliadis D, Duane Davis R, Steele MP, Messier RH, Lau CL, Eubanks SS, Palmer SM. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003;17:363–368.PubMed
93.
Zurück zum Zitat Sontag SJ, O’Connell S, Khandelwal S, Greenlee H, Schnell T, Nemchausky B, Chejfec G, Miller T, Seidel J, Sonnenberg A. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol 2003;98:987–999.PubMed Sontag SJ, O’Connell S, Khandelwal S, Greenlee H, Schnell T, Nemchausky B, Chejfec G, Miller T, Seidel J, Sonnenberg A. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol 2003;98:987–999.PubMed
94.
Zurück zum Zitat Patti MG, Tedesco P, Golden J, Hays S, Hoopes C, Meneghetti A, Damani T, Way LW. Idiopathic pulmonary fibrosis: how often is it really idiopathic? J Gastrointest Surg 2005;9:1053–1056; discussion 1056–1058.PubMed Patti MG, Tedesco P, Golden J, Hays S, Hoopes C, Meneghetti A, Damani T, Way LW. Idiopathic pulmonary fibrosis: how often is it really idiopathic? J Gastrointest Surg 2005;9:1053–1056; discussion 1056–1058.PubMed
95.
Zurück zum Zitat Zaman A, Hapke R, Flora K, Rosen H, Benner K. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol 1999;94:895–899.PubMed Zaman A, Hapke R, Flora K, Rosen H, Benner K. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol 1999;94:895–899.PubMed
96.
Zurück zum Zitat Karasu Z, Hulagu S, Gurakar A, Jazzar A, Kerwin B, Taydas E, McMillon G, Sebastian A, Wright H, Nour B. High incidence of noninfectious esophagitis in orthotopic liver transplant (OLT) recipients. J Okla State Med Assoc 2001;94:43–45.PubMed Karasu Z, Hulagu S, Gurakar A, Jazzar A, Kerwin B, Taydas E, McMillon G, Sebastian A, Wright H, Nour B. High incidence of noninfectious esophagitis in orthotopic liver transplant (OLT) recipients. J Okla State Med Assoc 2001;94:43–45.PubMed
97.
Zurück zum Zitat Fass R, Landau O, Kovacs TO, Ippoliti AF. Esophageal motility abnormalities in cirrhotic patients before and after endoscopic variceal treatment. Am J Gastroenterol 1997;92:941–946.PubMed Fass R, Landau O, Kovacs TO, Ippoliti AF. Esophageal motility abnormalities in cirrhotic patients before and after endoscopic variceal treatment. Am J Gastroenterol 1997;92:941–946.PubMed
98.
Zurück zum Zitat Stanciu C, Cijevschi C, Pandele G, Sandulescu E. Lower esophageal sphincter pressure before and after paracentesis in cirrhotic patients with intractable ascites. Digestion 1982;23:116–118.PubMed Stanciu C, Cijevschi C, Pandele G, Sandulescu E. Lower esophageal sphincter pressure before and after paracentesis in cirrhotic patients with intractable ascites. Digestion 1982;23:116–118.PubMed
99.
Zurück zum Zitat Cobb WS, Heniford BT, Burns JM, Carbonell AM, Matthews BD, Kercher KW. Cirrhosis is not a contraindication to laparoscopic surgery. Sug Endosc 2005;19:418-423. Cobb WS, Heniford BT, Burns JM, Carbonell AM, Matthews BD, Kercher KW. Cirrhosis is not a contraindication to laparoscopic surgery. Sug Endosc 2005;19:418-423.
100.
Zurück zum Zitat Dallal RM, Mattar SG, Lord JL, Watson AR, Cottam DR, Eid GM, Hamad G, Rabinovitz M, Schauer PR. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg 2004;14:47–53.PubMed Dallal RM, Mattar SG, Lord JL, Watson AR, Cottam DR, Eid GM, Hamad G, Rabinovitz M, Schauer PR. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg 2004;14:47–53.PubMed
101.
Zurück zum Zitat Conio M, Filiberti R, Blanchi S, Ferraris R, Marchi S, Ravelli P, Lapertosa G, Iaquinto G, Sablich R, Gusmaroli R, Aste H, Giacosa A. Risk factors for Barrett’s esophagus: a case-control study. Int J Cancer 2002;97:225–229.PubMed Conio M, Filiberti R, Blanchi S, Ferraris R, Marchi S, Ravelli P, Lapertosa G, Iaquinto G, Sablich R, Gusmaroli R, Aste H, Giacosa A. Risk factors for Barrett’s esophagus: a case-control study. Int J Cancer 2002;97:225–229.PubMed
102.
Zurück zum Zitat Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett’s esophagus. Am J Gastroenterol 1998;93:536–541.PubMed Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett’s esophagus. Am J Gastroenterol 1998;93:536–541.PubMed
103.
Zurück zum Zitat el-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am 2002;31:421–440, viii.PubMed el-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am 2002;31:421–440, viii.PubMed
104.
Zurück zum Zitat DeVault KR. Epidemiology and significance of Barrett’s esophagus. Dig Dis 2000;18:195–202.PubMed DeVault KR. Epidemiology and significance of Barrett’s esophagus. Dig Dis 2000;18:195–202.PubMed
105.
Zurück zum Zitat Sharma P. Barrett esophagus: will effective treatment prevent the risk of progression to esophageal adenocarcinoma? Am J Med 2004;117 Suppl 5A:79S–85S.PubMed Sharma P. Barrett esophagus: will effective treatment prevent the risk of progression to esophageal adenocarcinoma? Am J Med 2004;117 Suppl 5A:79S–85S.PubMed
106.
Zurück zum Zitat Shahhen NJ. Does fundoplication change the risk of esophageal cancer in the setting of GERD? Am J Gastroenterol 2005;100:1009–1011. Shahhen NJ. Does fundoplication change the risk of esophageal cancer in the setting of GERD? Am J Gastroenterol 2005;100:1009–1011.
107.
Zurück zum Zitat Rossi M, Barreca M, de Bortoli N, Renzi C, Santi S, Gennai A, Bellini M, Costa F, Conio M, Marchi S. Efficacy of Nissen fundoplication verus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg 2006;243:58–63.PubMed Rossi M, Barreca M, de Bortoli N, Renzi C, Santi S, Gennai A, Bellini M, Costa F, Conio M, Marchi S. Efficacy of Nissen fundoplication verus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg 2006;243:58–63.PubMed
108.
Zurück zum Zitat Corey KE, Schmitz SM, Shaheen NJ. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett’s esophagus? A meta-analysis. Am J Gastroenterol 2003;98:2390–2394.PubMed Corey KE, Schmitz SM, Shaheen NJ. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett’s esophagus? A meta-analysis. Am J Gastroenterol 2003;98:2390–2394.PubMed
109.
Zurück zum Zitat O’Riordan JM, Byrne PJ, Ravi N, Keeling PW, Reynolds JV. Long-term clinical and pathologic response of Barrett’s esophagus after antireflux surgery. Am J Surg 2004;188:27–33.PubMed O’Riordan JM, Byrne PJ, Ravi N, Keeling PW, Reynolds JV. Long-term clinical and pathologic response of Barrett’s esophagus after antireflux surgery. Am J Surg 2004;188:27–33.PubMed
110.
Zurück zum Zitat Romero Y, Cameron AJ, Locke JR 3rd, Schaid DJ, Slezak JM, Branch CD, Melton LJ, 3rd. Familial aggregation of gastroesophageal reflux in patients with Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology 1997;113:1449–1456.PubMed Romero Y, Cameron AJ, Locke JR 3rd, Schaid DJ, Slezak JM, Branch CD, Melton LJ, 3rd. Familial aggregation of gastroesophageal reflux in patients with Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology 1997;113:1449–1456.PubMed
111.
Zurück zum Zitat Bammer T, Hinder RA, Klaus A, Trastek VF, Achem SR. Rationale for surgical therapy of Barrett esophagus. Mayo Clin Proc 2001;76:335–340.PubMedCrossRef Bammer T, Hinder RA, Klaus A, Trastek VF, Achem SR. Rationale for surgical therapy of Barrett esophagus. Mayo Clin Proc 2001;76:335–340.PubMedCrossRef
112.
Zurück zum Zitat Pinotti AC, Cecconello I, Filho FM, Sakai P, Gama-Rodrigues JJ, Pinotti HW. Endoscopic ablation of Barrett’s esophagus using argon plasma coagulation: a prospective study after fundoplication. Dis Esophagus 2004;17:243–246.PubMed Pinotti AC, Cecconello I, Filho FM, Sakai P, Gama-Rodrigues JJ, Pinotti HW. Endoscopic ablation of Barrett’s esophagus using argon plasma coagulation: a prospective study after fundoplication. Dis Esophagus 2004;17:243–246.PubMed
113.
Zurück zum Zitat Braghetto I, Csendes A, Smok G, Gradiz M, Mariani V, Compan A, Guerra JF, Burdiles P, Korn O. Histological inflammatory changes after surgery at the epithelium of the distal esophagus 2004;17:235–242. Braghetto I, Csendes A, Smok G, Gradiz M, Mariani V, Compan A, Guerra JF, Burdiles P, Korn O. Histological inflammatory changes after surgery at the epithelium of the distal esophagus 2004;17:235–242.
114.
Zurück zum Zitat Kahrilas PJ. Surgical therapy for reflux disease. JAMA 2001;285:2376–2378.PubMed Kahrilas PJ. Surgical therapy for reflux disease. JAMA 2001;285:2376–2378.PubMed
115.
Zurück zum Zitat Sharma P. Gastro-oesophageal reflux disease: symptoms, erosions, and Barrett’s—what is the interplay? Gut 2005;54:739–740.PubMed Sharma P. Gastro-oesophageal reflux disease: symptoms, erosions, and Barrett’s—what is the interplay? Gut 2005;54:739–740.PubMed
116.
Zurück zum Zitat Jensdottir T, Arnadottir IB, Thorsdottir I, Bardow A, Gudmundsson K, Theodors A, Holbrook WP. Relationship between dental erosion, soft drink consumption, and gastroesophageal reflux among Icelanders. Clin Oral Investig 2004;8:91–96.PubMed Jensdottir T, Arnadottir IB, Thorsdottir I, Bardow A, Gudmundsson K, Theodors A, Holbrook WP. Relationship between dental erosion, soft drink consumption, and gastroesophageal reflux among Icelanders. Clin Oral Investig 2004;8:91–96.PubMed
117.
Zurück zum Zitat Raftopoulus I, Awais O, Courcoulas AP, Luketich JD. Laparoscopic gastric bypass after antireflux surgery for the treatment of gastroesophageal reflux in morbidly obese patients: initial experience. Obes Surg 2004;14:1373–1380. Raftopoulus I, Awais O, Courcoulas AP, Luketich JD. Laparoscopic gastric bypass after antireflux surgery for the treatment of gastroesophageal reflux in morbidly obese patients: initial experience. Obes Surg 2004;14:1373–1380.
118.
Zurück zum Zitat Kuipers EJ, Malfertheiner P. Helicobacter pylori and nonmalignant diseases. Helicobacter 2004;9 Suppl 1:29–34.PubMed Kuipers EJ, Malfertheiner P. Helicobacter pylori and nonmalignant diseases. Helicobacter 2004;9 Suppl 1:29–34.PubMed
119.
Zurück zum Zitat Katz PO. Management of the patient with Barrett’s esophagus: a continuing dilemma for the clinician. Rev Gastroenterol Disord 2004;4:49–59.PubMed Katz PO. Management of the patient with Barrett’s esophagus: a continuing dilemma for the clinician. Rev Gastroenterol Disord 2004;4:49–59.PubMed
120.
Zurück zum Zitat Corder AP, Jones RH, Sadler GH, Daniel P, Johnson CD. Heartburn, oesophagitis and Barrett’s oesophagus in self-medicating patients in general practice. Br J Clin Pract 1996;50:245–248.PubMed Corder AP, Jones RH, Sadler GH, Daniel P, Johnson CD. Heartburn, oesophagitis and Barrett’s oesophagus in self-medicating patients in general practice. Br J Clin Pract 1996;50:245–248.PubMed
121.
Zurück zum Zitat Pleskow D, Rothstein R, Lo S, Hawes R, Kozarek R, Haber G, Gostout C, Lembo A. Endoscopic full-thickness plication for the treatment of GERD: a multicenter trial. Gastrointest Endosc 2004;59:163–171.PubMed Pleskow D, Rothstein R, Lo S, Hawes R, Kozarek R, Haber G, Gostout C, Lembo A. Endoscopic full-thickness plication for the treatment of GERD: a multicenter trial. Gastrointest Endosc 2004;59:163–171.PubMed
122.
Zurück zum Zitat Neuhauser B, Bonatti H, Hinder RA. Treatment strategies for gastroesophageal reflux disease. Chirurg 2003;74:617–624; discussion 624–615.PubMed Neuhauser B, Bonatti H, Hinder RA. Treatment strategies for gastroesophageal reflux disease. Chirurg 2003;74:617–624; discussion 624–615.PubMed
123.
Zurück zum Zitat Hunter JG, Trus TL, Branum GD, Waring JP, Wood WC. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 1996;223:673–685; discussion 685–677.PubMed Hunter JG, Trus TL, Branum GD, Waring JP, Wood WC. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 1996;223:673–685; discussion 685–677.PubMed
124.
Zurück zum Zitat Lundell L. Surgery of gastroesophageal reflux disease: a competitive or complementary procedure? Dig Dis 2004;22:161–170.PubMed Lundell L. Surgery of gastroesophageal reflux disease: a competitive or complementary procedure? Dig Dis 2004;22:161–170.PubMed
125.
Zurück zum Zitat Pasricha PJ, Pham BV. Endoscopic therapy for GERD: is the evidence of efficacy Any stronger? Curr Treat Options Gastroenterol 2006;9:59–68.PubMed Pasricha PJ, Pham BV. Endoscopic therapy for GERD: is the evidence of efficacy Any stronger? Curr Treat Options Gastroenterol 2006;9:59–68.PubMed
Metadaten
Titel
Impact of Changing Epidemiology of Gastroesophageal Reflux Disease on its Diagnosis and Treatment
verfasst von
Hugo Bonatti
Sami R. Achem
Ronald A. Hinder
Publikationsdatum
01.02.2008
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 2/2008
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-007-0294-9

Weitere Artikel der Ausgabe 2/2008

Journal of Gastrointestinal Surgery 2/2008 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.